A237690 Stock Overview
ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 1/6 |
ST Pharm Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩88,200.00 |
52 Week High | ₩99,000.00 |
52 Week Low | ₩59,900.00 |
Beta | 0.69 |
1 Month Change | 33.43% |
3 Month Change | 30.09% |
1 Year Change | 20.33% |
3 Year Change | 3.40% |
5 Year Change | 300.91% |
Change since IPO | 80.74% |
Recent News & Updates
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Recent updates
Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26Shareholder Returns
A237690 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | 0.6% | -1.7% | 3.8% |
1Y | 20.3% | 6.2% | 13.0% |
Return vs Industry: A237690 exceeded the KR Life Sciences industry which returned 6.2% over the past year.
Return vs Market: A237690 exceeded the KR Market which returned 13% over the past year.
Price Volatility
A237690 volatility | |
---|---|
A237690 Average Weekly Movement | 10.1% |
Life Sciences Industry Average Movement | 7.3% |
Market Average Movement | 5.3% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A237690's share price has been volatile over the past 3 months.
Volatility Over Time: A237690's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 645 | Peter Kim | https://www.stpharm.co.kr |
ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions.
ST Pharm Co.,Ltd. Fundamentals Summary
A237690 fundamental statistics | |
---|---|
Market cap | ₩1.66t |
Earnings (TTM) | ₩19.58b |
Revenue (TTM) | ₩284.99b |
84.7x
P/E Ratio5.8x
P/S RatioIs A237690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A237690 income statement (TTM) | |
---|---|
Revenue | ₩284.99b |
Cost of Revenue | ₩175.25b |
Gross Profit | ₩109.74b |
Other Expenses | ₩90.16b |
Earnings | ₩19.58b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.04k |
Gross Margin | 38.51% |
Net Profit Margin | 6.87% |
Debt/Equity Ratio | 48.8% |
How did A237690 perform over the long term?
See historical performance and comparison